3Caballero B. Brain serotonin and carbohydrate craving in obesity[J]. Int J Obes, 1987,11( Supple 3 ) : 179-183.
4Bjǒmtorp PB,Bosmond. Obesity and cortisol[J]. Nutrition,2000,16(10) :924-936.
5Rittenhouse PA, Bakkum EA, Levy AD, et al. Evidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2C) receptors[ J ]. J Pharmacol Exp Ther,1994,271(3) :1647-1655.
6Rosmond R, Bouchard C, Bjorntorp P. Increased abdominal obesity in subjects with a mutation in the 5-HT2A receptor gene promoter[J]. Ann N Y Acad Sci,2002,967(6) :571-575.
7Aubert R,Betoulle D,Herbeth B,et al. 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people[J].Int J Obes Relat Metab Disord,2000,24(7):920-924.
8William J, Gilliam S, Mcguffin P, et al. Association between schizophrenia and T 102 C polymorphism d 5-hydroxytrytamine type 2A receptor gene[ J ]. The Lancet, 1996,347(9011) : 1294-1296.
9Ananz M,Collier D,Sodhi M,et al. Association between clozapine response and allelic variation in the 5-HT2A receptor gene[J]. The Lancet, 1995,346(8790) :281-282.
10Ricca V,Nacmias B,Cellini E,et al. 5-HT2A receptor gene polymorphism and eating disorders [ J ]. Neurosci Lett, 2002,323(2) : 105-108.
二级参考文献7
1Collier D A，Lancet，1997年，350卷，412页
2Moore N A，Current Opinion Investigation Drugs，1993年，2卷，281页
3Marlatt GA,Baer JS.Addictive behaviors: etiology and treatment[].Annual Review of Psychology.1988
4Mclellan AT,Luborsky L,Woody G,et al.An improved diagnostic evaluation instrument for substance abuse patients:the Addiction Severit y Index[].Journal of Nervous and Mental Disease.1980
5Kosten TR,Rounsaville BJ,Kleber HD.Multidimensionalit y and predictoin of treatment outcome in opioid addicts: a 2. 5 year follow-up[].Comprehensive Psychiatry.1987
6Crits-christoph P,Si gueland L.Psychosocial treatment for drug abuse[].Archives of General Psychiatry.1996
7O ’ Brien MW,Biase DV.Therapeutic communit y (TC): a coming of age.In: Lowinsom JH, Ruiz P, Millm RB eds.Drug abuse: a comprehensive textbook. 2nd Ed[].Batimore Williams Wilkins.1992
1Collier DA, Arranz MJ, Li T, et al. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet 1997; 350(9075): 412
2Hinney A, Ziegler A, Nothen MM, et al. 5-HT2A receptor gene polymorphisms,anorexia nervosa, and obesity. Lancet 1997;350(9087): 1324 -5
3Campbell DA, Sundaramurthy D, Markham AF, et al. Lack of association between5-HT2A gene promoter polymorphism and susceptibility to anorexia nervosa. Lancet 1998; 351 (9101): 499
4Enoch MA, Kaye WH, Rotondo A, et al. 5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 1998;351 (9118): 1785 -6
5Ando T, Komaki G, Karibe M, et al. 5-HT2A promoter polymorphism is not associated with anorexia nervosa in Japanese patients. Psychiatr Genet 2001; 11 (3):157 - 60
6Sorbi S, Nacmias B, Tedde A, et al. 5-HT2A promoter polymorphism in anorexia nervosa. Lancet 1998;351(9118): 17858
7汪向东 王希林 马弘.心理卫生评定量表手册.中国心理卫生杂志,1999,12:217-217.
8H. C. Ong, et al. Malay ethno-medico botany in Machang,Kelantan, Malaysia. Fitoterapia, 1999,70 (50):502.
9Keigo Nakatani, et al. Inhibition of cyclooxygenase and prostaglandin E2 synthesis by γ-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells. Biochemical Pharmacology, 2002,63 (1) : 73.
10Suksamrarn S, et al. Xanthones from the green fruit hulls of Garcinia mangostana. J Nat Prod, 2002,65 (5) : 761.
